2025 MCTC Project List
Below are 10 MCTC planned projects in 2025.
We sincerely invite you to join us and collaborate on these initiatives. We welcome dedicated participants who are committed to contributing their time and effort, with active engagement in regular online meetings.
We sincerely invite you to join us and collaborate on these initiatives. We welcome dedicated participants who are committed to contributing their time and effort, with active engagement in regular online meetings.
1. Criteria for IIM remission & LDA criteria
Developing and Validating “Remission” and “Low Disease Activity” Criteria for Idiopathic Inflammatory Myopathies
Project Leader: Nantakarn Pongtarakulpanit, Shiri Keret
Email: [email protected]
2. Definition of IIM-ILD progression
Sandardizing the Definition of IIM-ILD and IIM-ILD progression
Project Leader: Faye Pais, Vivik Nagaraja
Project Co-leader: Robert Hallowell, Erin Wilfong
Email: [email protected]
3. Criteria for IIM worsening
Evaluation and Revision of the “Clinical Worsening”
Definition in IIM Clinical Trials
Project Leader: lazsmin Ventura
Project Co-leader: Valérie Leclair, Francisca Bozan
Email: [email protected]
4. Consensus on IIM outcome measures
Appropriateness and Feasibility of Outcome Measures in IIM
Project Leader: Kaveh Ardalan
Project Co-leader: Akira Yoshida
Email: [email protected]
5. Global study recruitment patterns
Global Patterns and Challenges in Patient Recruitment for Idiopathic Inflammatory Myopathy Clinical Trials: Results from the 2024 MCTC Investigators’ Survey
Project Leader: Iris Tang
Project Co-leader: Kaushik sreeram
Email: [email protected]
6. Gaps in assessment expertise
Gaps in Training and Expertise in Myositis Outcome Measures: Insights from the 2024 MCTC Investigators’ Survey
Project Leader: Shiri Keret
Project Co-leader: Prateek Gandiga
Email: [email protected]
7. Characteristics of trial versus non-study IIM patients
Characteristics of IIM Patients Enrolled in Clinical Trials Compared to “Non-Study” IIM Populations
Project Leader: Edoardo Conticini
Project Co-leader: Iris Tang
Email: [email protected]
8. Duration of IIM clinical trials
Assessment of the Potential for Shorter Duration of IIM Clinical Trials (52 vs. 24 weeks)
Project Learder: Akira Yoshida
Project Co-leader: Eduardo Dourado
Email: [email protected]
9. Fair market value in IIM trials’ budgets
Scoping of Perceived Reasonable Fair Market Values in Myositis Clinical Trials
Project Leader: Prateek
Project Co-leader: Sabeena Usman
Email: [email protected]
10. IVIG pharmacokinetics & dosing
Pharmacokinetics and Optimal Dosing of IVIG in Dermatomyositis